BOSTON SCIENTIFIC CORPORATION Income Tax Examination, Penalties and Interest Expense
BOSTON SCIENTIFIC CORPORATION (BSX) reported Income Tax Examination, Penalties and Interest Expense of $7.00 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-23.
Discontinued › Expense Statement › Interest Expense
us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense · last filed 2021-02-23
- BOSTON SCIENTIFIC CORPORATION income tax examination, penalties and interest expense for fiscal 2020 was $7.00M, a 600.00% increase from fiscal 2019.
- BOSTON SCIENTIFIC CORPORATION income tax examination, penalties and interest expense for fiscal 2019 was $1.00M, a 99.80% decline from fiscal 2018.
- BOSTON SCIENTIFIC CORPORATION income tax examination, penalties and interest expense for fiscal 2018 was $498.00M, a 223.38% increase from fiscal 2017.
- BOSTON SCIENTIFIC CORPORATION income tax examination, penalties and interest expense for fiscal 2017 was $154.00M, a 234.78% increase from fiscal 2016.
| Period end | Income Tax Examination, Penalties and Interest Expense 6 month | Income Tax Examination, Penalties and Interest Expense 12 month | Income Tax Examination, Penalties and Interest Expense 12 month as first filed |
|---|---|---|---|
| 2020-12-31 | $7.00M 10-K · filed 2021-02-23 | ||
| 2019-12-31 | $1.00M 10-K · filed 2021-02-23 | -$1.00M 10-K · filed 2020-02-25 | |
| 2018-12-31 | $498.00M 10-K · filed 2021-02-23 | ||
| 2017-12-31 | $154.00M 10-K · filed 2020-02-25 | ||
| 2016-12-31 | $46.00M 10-K · filed 2019-02-19 | ||
| 2015-12-31 | $37.00M 10-K · filed 2018-02-20 | ||
| 2014-12-31 | $26.00M 10-K · filed 2017-02-23 | ||
| 2013-12-31 | $22.00M 10-K · filed 2016-02-24 | ||
| 2012-12-31 | $34.00M 10-K · filed 2015-02-25 | ||
| 2011-12-31 | $18.00M 10-K · filed 2014-02-26 | ||
| 2010-12-31 | $14.00M 8-K · filed 2013-05-29 | ||
| 2010-06-30 | $64.00M 10-Q · filed 2010-08-05 | ||
| 2009-12-31 | $31.00M 10-K · filed 2012-02-17 | $64.00M 10-Q · filed 2010-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |